about
Long Non-coding RNAs and Their Roles in Non-small-cell Lung CancerMitochondrial ROS and cancer drug resistance: Implications for therapyIntegrated epigenetics of human breast cancer: synoptic investigation of targeted genes, microRNAs and proteins upon demethylation treatmentDNA methylation-independent reversion of gemcitabine resistance by hydralazine in cervical cancer cellsGenome-wide analysis of miRNA signature differentially expressed in doxorubicin-resistant and parental human hepatocellular carcinoma cell linesNoninvasive visualization of microRNA-16 in the chemoresistance of gastric cancer using a dual reporter gene imaging systemUpregulation of miR-21 in cisplatin resistant ovarian cancer via JNK-1/c-Jun pathwaymicroRNA-200a-3p increases 5-fluorouracil resistance by regulating dual specificity phosphatase 6 expression.MicroRNA-mRNA functional pairs for cisplatin resistance in ovarian cancer cells.Resistance to cancer chemotherapeutic drugs is determined by pivotal microRNA regulators.In vitro antiproliferative activity of partially purified Trigona laeviceps propolis from Thailand on human cancer cell lines.MiR-224 promotes the chemoresistance of human lung adenocarcinoma cells to cisplatin via regulating G₁/S transition and apoptosis by targeting p21(WAF1/CIP1).Haemolysis during sample preparation alters microRNA content of plasma.A long non-coding RNA snaR contributes to 5-fluorouracil resistance in human colon cancer cells.MicroRNAs: key players of taxane resistance and their therapeutic potential in human cancers.miR-497 modulates multidrug resistance of human cancer cell lines by targeting BCL2.MicroRNA-217 functions as a tumour suppressor gene and correlates with cell resistance to cisplatin in lung cancer.Characterization and comparative profiling of miRNAs in invasive Bemisia tabaci (Gennadius) B and QUpregulation of microRNA-451 increases cisplatin sensitivity of non-small cell lung cancer cell line (A549).MicroRNA-25 regulates small cell lung cancer cell development and cell cycle through cyclin E2MicroRNA gene dosage alterations and drug response in lung cancerMicroRNA-519a is a novel oncomir conferring tamoxifen resistance by targeting a network of tumour-suppressor genes in ER+ breast cancer.The long noncoding RNA HOTAIR contributes to cisplatin resistance of human lung adenocarcinoma cells via downregualtion of p21(WAF1/CIP1) expressionA high-throughput screen identifies miRNA inhibitors regulating lung cancer cell survival and response to paclitaxel.Validation of miRNA-mRNA interactions by electrophoretic mobility shift assays.MiR-193b promotes autophagy and non-apoptotic cell death in oesophageal cancer cellsReversal of microRNA-150 silencing disadvantages crizotinib-resistant NPM-ALK(+) cell growthmiR-200c/Bmi1 axis and epithelial-mesenchymal transition contribute to acquired resistance to BRAF inhibitor treatment.Clarifying the molecular mechanism associated with carfilzomib resistance in human multiple myeloma using microarray gene expression profile and genetic interaction networkOverexpression of miR-100 inhibits cell proliferation, migration, and chemosensitivity in human glioblastoma through FGFR3MiR-494 is regulated by ERK1/2 and modulates TRAIL-induced apoptosis in non-small-cell lung cancer through BIM down-regulation.Genome-wide analysis of differentially expressed miRNA in PLX4720-resistant and parental human thyroid cancer cell lines.Cisplatin sensitivity mediated by WEE1 and CHK1 is mediated by miR-155 and the miR-15 family.Contributions of microRNA dysregulation to cisplatin resistance in adenocarcinoma cells.miR-302b enhances breast cancer cell sensitivity to cisplatin by regulating E2F1 and the cellular DNA damage response.Inhibition of p38 mitogen-activated protein kinase alters microRNA expression and reverses epithelial-to-mesenchymal transition.MiR-449a promotes breast cancer progression by targeting CRIP2.Post-transcriptional controls by ribonucleoprotein complexes in the acquisition of drug resistance.MicroRNA 203 Modulates Glioma Cell Migration via Robo1/ERK/MMP-9 Signaling.Deregulation of let-7e in epithelial ovarian cancer promotes the development of resistance to cisplatin.
P2860
Q26743412-5F143A61-F65A-419B-8E3B-69693D83279CQ26798106-5BAF65FA-77BD-4314-91D5-4031DA7952D9Q28477824-586A3FD6-0AE6-467C-A0A4-31E323938424Q28481440-783EC8DD-F2AA-47D4-8910-D5A73D6CEA18Q28485293-673092A3-E649-442B-8B48-3BD017DD01F7Q28486245-EB709168-73FF-4F18-ADBA-AD550526A139Q28539122-E9FC5287-BFCC-4B01-A8C0-39F93263BC47Q33754032-936042A2-CCAB-4BC7-BA36-A07A3CD479C8Q33764106-DE80FD01-AE32-42BB-952D-722184B28F4DQ33850064-3EFBC622-4AE1-4A56-B11C-8F5C26B63BD2Q33891498-E5624D35-E4BC-4C11-A6FB-BE89BBBB08F5Q33918050-10B1AF71-2433-46B1-8F49-1EB89F09589AQ34016595-2CC2A54C-E0F9-4E1A-831C-092BEE526AD0Q34043011-78CB2D0C-7DEE-4FD8-8176-69AA4243E8F0Q34154782-6C4EF2CB-F89D-4979-8EF6-51E583731B78Q34160439-29FA1CAA-9F7E-45F6-BF95-DA6F64EBAA0DQ34263317-6CC12640-8442-4320-8352-B36515E88460Q34635567-DA750BC8-1220-4D3A-8C66-CBCA2619FD30Q34638253-094ADAC6-C2C2-4BAC-AE79-D15D367CAB52Q34733320-5244043E-74CE-40F6-9FD0-26562F78FDE1Q34897598-37B3D481-3E1E-4242-8C97-A085091F4EF8Q34984068-76D9194A-19B5-4428-9E6A-18AA2B01A7E2Q35025421-5271755D-C5B4-46E0-B369-B8DA49697C0CQ35025917-1ACBFD67-61EC-428A-9312-12103B430534Q35038539-5A7B4368-F00A-450F-956D-16CDD4DF4108Q35924139-F0FFA3C8-55D9-4857-9EF4-883B9C97972DQ36106068-699CAF91-6625-428F-B0B7-26AE888B9576Q36135379-A02E34E1-A59B-42C1-9C59-159F0A81BF47Q36303485-262C85B3-05B7-4414-AF05-65BDDBD03CA6Q36307209-D0EB1F87-644C-40FA-8DEA-BB7F1D417E7CQ36339939-E2E900B1-71B2-4FDD-BB34-BAB4050F587EQ36396159-8AFC5DFE-5248-4B82-8F41-FD6F65E4FB97Q36405766-1D1A116D-988F-4EDE-9A16-530EDC6AF681Q36585797-DD548804-6B32-47D4-BE48-2CB32B968ED6Q36729533-5D01A0FA-DA13-42B4-A033-5490CE430AE8Q36755634-FE698A28-DD9C-46EB-9404-0385D91AB3A5Q37109894-C503DF14-4D6F-455A-927B-6F6A0A56A425Q37139289-0B7F40F4-1D4E-481C-B81A-9DFBF3EF0BE0Q37253571-99521152-D13F-4185-9154-F37396CFD856Q37275739-CB097C95-66A6-4FFA-9975-CF651297DC78
P2860
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on 14 May 2010
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
MicroRNA and drug resistance.
@en
MicroRNA and drug resistance.
@nl
type
label
MicroRNA and drug resistance.
@en
MicroRNA and drug resistance.
@nl
prefLabel
MicroRNA and drug resistance.
@en
MicroRNA and drug resistance.
@nl
P2093
P2860
P356
P1433
P1476
MicroRNA and drug resistance.
@en
P2093
P2860
P2888
P304
P356
10.1038/CGT.2010.18
P577
2010-05-14T00:00:00Z